# Immatics: The global leader in precision targeting of PRAME
> Immatics is developing novel immunotherapies to recognize and eliminate cancer cells that present PRAME. They have the broadest PRAME franchise with the most indications and therapeutic modalities.

## The Science and 
- [Our Science](https://immatics.com/our-science): Main capabilities, unique selling points, and benefits.
- [Pipeline](https://immatics.com/pipeline): Answers to common pre-purchase questions and objections.
- [Publications and Presentations](https://immatics.com/scientific-publications-presentations): Subscription tiers, what is included, and enterprise options.

## Company Overview
- [About Us](https://immatics.com/about): Company mission, history, and quick facts about Immatics’ PRAME leadership.
- [Leadership](https://immatics.com/leadership): Meet the company leadership team at Immatics.
- [Board of Directors](https://immatics.com/board-of-directors): Meet the Board of Directors at Immatics.
- [Scientific Advisory Board](https://immatics.com/scientific-advisory-board): Meet the Scientific Advisory Board at Immatics.
- [Collaborations](https://immatics.com/collaborations): Strategic collaborations with key industry partners.

## Clinical Trials
- [Overview of Clinical Trials](https://immatics.com/overview-clinical-trials): Latest news on clinical trials and find a trial site near you.
- [Expanded Access Policy](https://immatics.com/expanded-access-policy): Policy and expanded access programs.

## Careers
- [Working at Immatics](https://immatics.com/working-at-immatics): Mission and purpose, culture, values, and current jobs.
- [Jobs in the US](https://immatics.com/jobs-us): Current job information for US candidates.
- [Jobs in Germany](https://immatics.com/jobs-de): Current job information for German candidates.

## News and Contact Information
- [Contact Us](https://immatics.com/contact): Get in touch with Immatics.
- [Newsroom](https://investors.immatics.com/press-releases): Investor news and press releases.